Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting

Psychiatria Danubina

Volumn 20, Issue 3, 2008, Pages 323-328

  Raja, Michele ^a,b   Azzoni, Antonella ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Aripiprazole; Emergency; Psychotic disorders; Therapy

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMERGENCY CARE; FEMALE; GENERAL HOSPITAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; PSYCHOSIS; PSYCHOTHERAPY; SINGLE DRUG DOSE; SYMPTOM; UNSPECIFIED SIDE EFFECT;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; EMERGENCY SERVICES, PSYCHIATRIC; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PIPERAZINES; PSYCHIATRIC DEPARTMENT, HOSPITAL; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUINOLONES; RISPERIDONE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 54349117917     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Centorrino F, Fogarty KV, Cimbolli P, et al. Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients. J Psychiatr Pract 2005;11:241-7.
2. Christensen AF, Poulsen J, Nielsen CT, Bork B, Christensen A, Christensen M. Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study. Acta Psychiatr Scand 2006;113:148-53.
3. DeQuardo JR. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism? J Clin Psychiatry 2002;63:763-71.
4. Di Lorenzo R, Amoretti A, Forghieri M, Fiorini F, Genedani S, Rigatelli M. Aripiprazole: effectivenes, and safety under naturalistic conditions. Experim Clin Psychopharmacol 2007;15:569-75.
5. Grover S, Sharan P, Gupta N. Aripiprazole worsens psychosis: a case report. Prim Care Companion J Clin Psychiatry 2006;8:380-1.
6. Haines A, Jones R. Education and debate. Implementing findings of research. British Medical Journal 1994;308:1488-92.
7. Hamann J, Adjan S, Leucht S, Kissling W. Psychiatric decision making in the adoption of a new antipsychotic in Germany. Psychiatr Serv 2006;57:700-3.
8. Keck PE Jr, Marcus R, Tourkodimitris S, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003;160:1651-8.
9. McEvoy JP, Daniel DG, Carson WH Jr, McQuade RD, Marcus RM. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia. J Psychiatr Res 2007;41:895-905.
10. Morrison EF. A hierarchy of aggressive and violent behaviors among psychiatric inpatients. Hosp Commun Psychiatry 1992;43:505-6.
11. Raja M. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole. Int J Neuropsychopharmacol 2007; 10:107-10.
12. Raja M, Azzoni A. Comparison of three antipsychotics in the emergency psychiatric setting. Hum Psychoharmacol Clin Experim 2003; 18:447-52.
13. Ramaswamy S, Vijay 19, William M, Sattar SP, Praveen F, Petty F. Aripiprazole possibly worsens psychosis. Int Clin Psychopharmacol 2004;19:45-8.
14. Reeves RR, Mack JE. Worsening schizoaffective disorder with aripiprazole. Am J Psychiatry 2004; 161:1308.